CITED2 is a conserved regulator of the uterine-placental interface

Establishment of the hemochorial uterine-placental interface requires exodus of trophoblast cells from the placenta and their transformative actions on the uterus, which represent processes critical for a successful pregnancy, but are poorly understood. We examined the involvement of CBP/p300-intera...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 120; no. 3; p. e2213622120
Main Authors Kuna, Marija, Dhakal, Pramod, Iqbal, Khursheed, Dominguez, Esteban M, Kent, Lindsey N, Muto, Masanaga, Moreno-Irusta, Ayelen, Kozai, Keisuke, Varberg, Kaela M, Okae, Hiroaki, Arima, Takahiro, Sucov, Henry M, Soares, Michael J
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 17.01.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Establishment of the hemochorial uterine-placental interface requires exodus of trophoblast cells from the placenta and their transformative actions on the uterus, which represent processes critical for a successful pregnancy, but are poorly understood. We examined the involvement of CBP/p300-interacting transactivator with glutamic acid/aspartic acid-rich carboxyl-terminal domain 2 (CITED2) in rat and human trophoblast cell development. The rat and human exhibit deep hemochorial placentation. CITED2 was distinctively expressed in the junctional zone (JZ) and invasive trophoblast cells of the rat. Homozygous gene deletion resulted in placental and fetal growth restriction. Small null placentas were characterized by disruptions in the JZ, delays in intrauterine trophoblast cell invasion, and compromised plasticity. In the human placentation site, CITED2 was uniquely expressed in the extravillous trophoblast (EVT) cell column and importantly contributed to the development of the EVT cell lineage. We conclude that CITED2 is a conserved regulator of deep hemochorial placentation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
3Present address: Eurofins BioPharma, Columbia, MO 65202.
5Present address: Department of Stem Cells and Human Disease Models, Research Center for Animal Life Science, Shiga University of Medical Science, Seta, Tsukinowa-cho, Otsu 520-2192, Japan.
Edited by Thomas Spencer, University of Missouri, Columbia, MO; received August 11, 2022; accepted December 6, 2022
6Present address: Department of Obstetrics and Gynecology, University of Missouri-Kansas City School of Medicine, Kansas City, MO 64108.
4Present address: Center for Reproductive Health Sciences, Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, MO 63110.
1M.K. and P.D. contributed equally to this work.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.2213622120